New head for Bayer’s NZ Consumer Care division

New head for Bayer’s NZ Consumer Care division

Auckland, 5 March, 2007 Bayer New Zealand Ltd has appointed Heiko Petersen as country division head of its OTC Consumer Care division.

Petersen, who will be based in Bayer’s Auckland office, has been with Bayer for eight years and previously worked in Bayer’s Consumer Care head office in Leverkusen, Germany.

He has a broad range of international experience, including working for Bayer in Latin America and Europe in the areas of supply chain, sales and marketing.

Before moving to New Zealand, he was a senior brand manager for Bayer Germany’s gastro intestinal range of products where under his direction brands such as Rennie and Talcid grew faster than market.

Petersen says he is looking forward to the challenge of growing Bayer’s OTC business in New Zealand, particularly its key brands Berocca®, Canesten®, Elevit®, Novalac® and Bepanthen®.

Bayer HealthCare

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. Bayer HealthCare generated sales amounting to some 9.4 billion euros and employed 33,800 people worldwide in 2005.

The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Bayer Schering Pharma (BSP) divisions. The new BSP division was established on January 1, 2007, and comprises the business from the former BHC and Schering AG business. The business units are: Women's Healthcare, Diagnostics Imaging, Primary Care, Specialized Therapeutics, Hematology/Cardiology, Oncology and Primary Care.

Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. The products enhance well-being and quality of life by diagnosing, preventing and treating diseases.

ENDS

© Scoop Media